This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zaessingue, FR (2012)
- Allschwil, CH (2013)
Company Filing History:
Years Active: 2012-2013
Title: Philippe Risch: Innovator in Prostaglandin Research
Introduction
Philippe Risch is a notable inventor based in Switzerland, recognized for his contributions to the field of pharmaceutical sciences. He has focused on developing compounds that modulate prostaglandin receptors, which play a crucial role in various biological processes.
Latest Patents
Philippe Risch holds a patent for "1-Phenyl-Substituted Heterocyclyl Derivatives And Their Use As Prostaglandin D2 Receptor Modulators." This invention relates to 1-phenyl-substituted heterocyclyl derivatives that are utilized as prostaglandin D2 receptor modulators. These compounds are significant in the treatment of various prostaglandin-mediated diseases and disorders. The patent outlines the chemical formula and the potential applications of these derivatives in pharmaceutical compositions.
Career Highlights
Philippe Risch is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to advance his research in the pharmaceutical industry. His work is pivotal in developing new therapeutic options for patients suffering from conditions related to prostaglandin activity.
Collaborations
Philippe has collaborated with esteemed colleagues such as Hamed Aissaoui and Christoph Boss, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Philippe Risch's work in prostaglandin receptor modulation exemplifies the importance of innovation in the pharmaceutical field. His contributions are paving the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile